Abstract
BackgroundHarnessing NK cells is proving to be an attractive strategy for cancer immunotherapy, either by activating endogenous NK cells or through adoptive cell transfer. NK cells can also be sourced...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have